Antisense and RNAi Technology

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Antisense and RNAi Technology

RNAi Price: $3,450.00 (€2,719.09) ($4,140.00 (€3,262.91) Including VAT at 20%) Publication Date: Jan-2012 Format: PDF Pages: 417 Publisher: RI Technologies Table of Contents Sample Pages This report covers both products and services in the RNAi industry. The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- United States, Europe, Asia-Pacific and Rest of World. The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, miRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and Electroporation), Monitoring/Optimizing (Primers for RTqPCR, Controls, and miRNA Detection Tools), and Libraries (Human, Mouse, and Rat). Application by Research (Functional Genomics, Metabolism, and Protein Chemistry), Therapeutics (Oncology, Neurology, Ophthalmology, and Virology) and Drug Development (Target Identification, Target Validation, and Drug Mechanism) are also analyzed. Business profiles of major companies are discussed in the report. The report serves as a guide to global RNAi industry covering 200 plus companies that are engaged in RNAi synthesis, R&D, therapeutics, test kits, tools and services. Major Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Estimations and predictions are provided by geographic regions with exclusive graphical representations illustrated for 350 plus exhibits.

MicroRNA Market Trends 2011 Please click here for more information or to purchase this report at our partner store Published: October 2011 Pages: 139 This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of vendors in the microRNA products space [for research on microRNAs], a detailed analysis of publication trends in the microRNA field based on an analysis of more than 20,000 technical publications on microRNAs to identify research trends and “hotspots” of microRNA research.

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 10-Jun-2011 Format: PDF Pages: 77 Publisher: GBI Research More...

RNA Therapeutics Pipeline Database: 1-Year Subscription Price Single User $847.00 Site License $1,694.00 Global License $2,541.00 Format: Online Database Publisher: La Merie Subscription to La Merie’s proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include the classes of antisense, aptamers, small interfering RNA (siRNA)/RNA interference (RNAi) or Locked Nucleic Acid (LNA) RNA. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources are conducted on a rotating, regular basis. Sample screenshots illustrate the database More...

Competitor Analysis RNA Therapeutics in Clinical Development Price Single User $561.00 Site License $1,122.00 Global License $1,683.00 Publication Date: Mar 2011 Format: PDF Pages: 67 Publisher: La Merie The present Competitive Intelligence Report about RNA Therapeutics in Clinical Development provides a competitor evaluation in the field of RNA based molecules being developed in clinical studies for treatment of a variety of clinical disorders as of February 2011. RNA based Therapetuics include antisense molecules, aptamers, Locked Nucleic Acid (LNA) RNA, siRNA/RNAi and CpG oligonucleotides. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. More...

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Feb-2010 Format: PDF Pages: 89 Publisher: GBI Research More...

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities Price: $1,432.00 (€1,128.62) ($1,718.40 (€1,354.34) Including VAT at 20%) Published: 01/07/2009 Pages: 225 Format: PDF Publisher: Pharmavision This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines. It provides opinions & market projections to: • assess the commercial potential of RNAi-based therapies in all of the key therapeutic areas: cancer, CNS disorders, viral infectious diseases, ocular diseases, cardiovascular, metabolic and other conditions; • identify key pharma & delivery specialists advancing RNAi-based therapeutics & diagnostics; • gain an in-depth understanding of the technological & delivery issues which face companies developing RNAi-based therapies; • evaluate the options available for chemically and structurally modifying RNAi silencing agents and delivering them to target tissues now & in the future; • discover which companies are tackling efficacy and safety issues & are in a prime position to exploit new opportunities; • analyze how the market will evolve over the next decade highlighting key trends, opportunities & challenges. Full Details Sample Pages

MicroRNA Research and Disease Associations 2010 Please click here for more information or to purchase this report at our partner store This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends—both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of different research product vendors into the end-user community, products for microRNA research in the various market segments, research market characteristics—number of experiments performed, research product pricing, segmentation of the microRNA research market across various research areas, and unmet market needs. Importantly, the key microRNA research market segments where a large opportunity exists are characterized and the penetrance of different technologies in these segments are presented in this market report.

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Antisense and RNAi Technology